<DOC>
	<DOCNO>NCT01679665</DOCNO>
	<brief_summary>Recently , inactivated vaccine ( vero cell ) EV71 investigate Phase 1 Phase 2 clinical trial . Data trial show EV71 vaccine good safety profile immunogenic . 320 U alum-adjuvant vaccine choose candidate vaccine phase 3 clinical trial . This clinical trial supplementary phase 2 trial , design study gene expression pattern induce EV71 vaccine Chinese healthy child age 2 5 year old use system biology approach combine microarray analysis，RT-PCR neutralizing antibody test PBMC serum collect form study child population , predict immunogenicity , explore mechanistic insight EV71 vaccine .</brief_summary>
	<brief_title>Systems Biology Vaccination EV71 Vaccine Humans</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy subject age 2 5 year old establish medical history clinical examination The prevaccination neutralize antibody EV71 &lt; 1:8 determined ELISA The subject ' guardian able understand sign inform consent Had never receive vaccine EV71 Subjects comply requirement protocol Subjects temperature ＜37.1°C axillary setting Subject medical history HFMD &lt; = 37 week gestation Subjects birth weight &lt; 2.5 kg Subject medical history following : allergic history , allergic ingredient vaccine Family history seizure progressive neurological disease Family history congenital hereditary immunodeficiency Severe malnutrition dysgenopathy Major congenital defect serious chronic illness , include perinatal brain damage Autoimmune disease Bleeding disorder diagnose doctor significant bruising bleed difficulty IM injection blood draw Any acute infection last 7 day Any prior administration immunodepressant corticosteroid last 6month Any prior administration blood product last 3 month Any prior administration research medicine last 1month Any prior administration attenuate live vaccine last 28 day Any prior administration inactivate vaccine last 14 day , pneumococcal vaccine Under anti TB prevention therapy Any condition opinion investigator , may interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>